[1]
Kulvinder Kochar Kaur, Gautam Allahbadia, and Mandeep Singh, “Optimizing Cardiovascular Outcome in Type 2 Diabetes Mellitus with Better Control of Diabetes Mellitus with Empigliflozin and Hypertension with Renin Angiotensin System Inhibitors and Manidipine Preferably of the Dihydropyridones”, OR, pp. 1–13, Jan. 2020.